Table 3.
ANOVA results indicating differences among the female study participants (n = 347) based on the study variables, using post hoc Scheffé tests.
| Factors | Dentists (n = 23), 95% CI | Dental Hygienists (n = 73), 95% CI | Adult Population (n = 251), 95% CI | F | Post hoc Scheffé |
|---|---|---|---|---|---|
| VAX score M (±SD) | 24.65 (±6.91), 21.66–27.64 | 31.47 (±9.76), 29.20–33.75 |
27.17 (±13.43), 25.50–28.84 | 4.25 * | 2 > 3 |
| COVID-VAX score M (±SD) | 27.13 (±5.78), 24.62–29.63 | 32.84 (±10.95), 30.29–35.40 |
29.94 (±13.93), 28.20–31.67 | 2.18 | |
| HCS score M (±SD) | 32.43 (±3.76), 30.80–34.06 | 35.15 (±6.01), 33.74–36.55 |
34.46 (±5.62), 33.76–35.16 |
2.05 | |
| VAX items #1–3 (mistrust of vaccine belief) | 4.73 (±2.17), 3.79–5.68 |
7.05 (±3.71), 6.18–7.92 |
6.19 (±3.94), 5.70–6.69 |
3.44 * | 1 < 2 |
| VAX items #4–6 (worries over unforeseen future effects) | 9.04 (±3.86), 7.37–10.71 |
11.39 (±3.51), 10.57–12.21 |
9.09 (±4.16), 8.57–9.61 |
9.49 ** | 2 > 3 |
| VAX items #7–9 (concerns about commercial profits) | 4.39 (±2.18), 3.44–5.33 |
5.49 (±2.73), 4.85–6.13 |
5.31 (±3.59), 4.87–5.76 |
0.96 | |
| VAX items #10–12 (preference to natural immunity) | 6.47 (±2.44), 5.42–7.53 |
7.53 (±3.47), 6.72–8.34 |
6.55 (±3.79), 6.08–7.02 |
2.08 | |
| COVID-VAX items #1–3 | 6.91 (±3.30), 5.48–8.34 |
8.53 (±3.85), 7.63–9.43 |
8.01 (±4.44), 7.46–8.56 |
1.29 | |
| COVID-VAX items #4–6 | 10.13 (±2.68), 8.96–11.29 |
10.58 (±3.39), 9.79–11.38 |
10.01 (±4.10), 9.50–10.52 |
0.62 | |
| COVID-VAX items #7–9 | 4.43 (±1.75), 3.67–5.19 |
6.34 (±3.74), 5.46–7.21 |
5.67 (±4.10), 5.16–6.18 |
2.17 | |
| COVID-VAX items #10–12 | 5.65 (±2.70). 4.48–6.82 |
7.38 (±3.33), 6.60–8.16 |
6.23 (±3.73), 5.77–6.70 |
3.45 * |
Notes: 1 = Dentists, 2 = Dental hygienists, 3 = Adult population, CI = Confidence interval, VAX score = vaccination attitudes, COVID-VAX score = COVID-19 vaccination attitudes, HCS score = awareness of health behaviors. * p ≤ 0.05; ** p ≤ 0.001.